Skip to main content
Caplight Logo









ElegsLab

ElegsLab

Private
BusanHealthcare & Life Scienceshttps://www.elegslab.com/

Last Round

Angel

Jan 28, 2025

Company Overview

ElegsLab is a biotechnology company that provides an AI-driven drug discovery and preclinical CRO platform utilizing microfluidic biochips and C. elegans models.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Biotech Equipment, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS, Hardware Sales

AI Layer

Application

Keywords

contract research organizationCROcontract development and manufacturing organizationCDMOdrug discoverypreclinical testingmicrofluidic biochiporgan-on-a-chipC. elegans modelhigh-throughput screeningtoxicity testingnanoformulationAI drug discoveryin silico testinganimal-free testinglab automation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ElegsLab Comparables

Compare ElegsLab with similar companies based on industry and business-model similarity.

ElegsLab comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
NemaLife
87%
vivoVerse
86%
Magnitude Biosciences
84%

ElegsLab Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AngelJan 28, 2025
SeedDec 1, 2024

ElegsLab Investors

Notable investors and investment history

ElegsLab investors
InvestorRounds
Busan United Technology HoldingsAngel, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 1, 2024

    Seed round led by Busan United Technology Holdings.

ElegsLab Filings

Explore SEC and related filing metadata, where available.

ElegsLab filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about ElegsLab's valuation, stock price, and market status.

Is ElegsLab a public or private company?

ElegsLab is a private company.

What is the current stock price of ElegsLab?

ElegsLab is a private company with no public stock price. Caplight tracks ElegsLab's secondary market activity and provides MarketPrice estimates to Caplight users.

How much is ElegsLab worth (valuation)?

Valuation information for ElegsLab is not publicly available.

Can I buy ElegsLab stock?

ElegsLab shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was ElegsLab's last funding round?

ElegsLab's most recent funding round was Angel on January 28, 2025.

Who are the main investors in ElegsLab?

Key investors in ElegsLab include Busan United Technology Holdings.

Will ElegsLab IPO soon?

No public IPO plans have been announced for ElegsLab.

How can I track ElegsLab secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ElegsLab's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBusan
Year Founded2023
Last FundingJan 28, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?